Published in Hepatitis Weekly, February 18th, 2002
Also participating in this financing round are investors from Achillion's prior financing, including Atlas Venture, Schroder Ventures, Advent International and Connecticut Innovations, and new investors including KBL Healthcare, ING Furman Selz, Pacific Growth Equities, Oakwood Medical, Webster...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.